Most, [8]–[10] but not all [18F]-fluorodeoxyglucose (FDG) PET studies [11]–[13] have shown hypometabolism in AD-related regions in APOE4 carriers in late-middle age [8] and even earlier [10]. The gene discussed is APOE; the disease is Alzheimer disease.